Experiment 1087485

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationNATALE,RB: GRALLA,RJ: WITTES,RE:. (1981). PHASE II TRIAL OF VINDESINE IN PATIENTS WITH SMALL CELL LUNG CARCINOMA.. 65()
Amount utilized
Compound isolated
DiseaseA PHASE II STUDY IN PATIENTS(26) WITH OBJECTIVELY MEASURABLE AND HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CARCINOMA.MAJOR OBJECTIVE RESPONSE OCCURRED IN 5 OF 24 ADEQUATELY TREATED PATIENTS. NEUROTOXICITY, MANIFESTED BY PARESTHESIAS,DECREASE IN DEEP TENDON REFLEXES,MYALGIAS,MUSCLE WEAKNESS, OR CONSTIPATION, WAS COMMON, BUT WELL TOLERATED. IT WAS NOT DOSE-LIMITING AND DID NOT REQUIRE DOSE ATTENUATION.
Dose amount3.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES